110 related articles for article (PubMed ID: 11559086)
1. Molecular modeling of bifunctional chelate peptide conjugates. 1. Copper and indium parameters for the AMBER force field.
Reichert DE; Norrby PO; Welch MJ
Inorg Chem; 2001 Sep; 40(20):5223-30. PubMed ID: 11559086
[TBL] [Abstract][Full Text] [Related]
2. Bifunctional chelators for copper radiopharmaceuticals: the synthesis of [Cu(ATSM)-amino acid] and [Cu(ATSM)-octreotide] conjugates.
Cowley AR; Dilworth JR; Donnelly PS; Heslop JM; Ratcliffe SJ
Dalton Trans; 2007 Jan; (2):209-17. PubMed ID: 17180189
[TBL] [Abstract][Full Text] [Related]
3. QSAR studies of copper azamacrocycles and thiosemicarbazones: MM3 parameter development and prediction of biological properties.
Wolohan P; Yoo J; Welch MJ; Reichert DE
J Med Chem; 2005 Aug; 48(17):5561-9. PubMed ID: 16107156
[TBL] [Abstract][Full Text] [Related]
4. The synthesis and chelation chemistry of DOTA-peptide conjugates.
De León-Rodríguez LM; Kovacs Z
Bioconjug Chem; 2008 Feb; 19(2):391-402. PubMed ID: 18072717
[TBL] [Abstract][Full Text] [Related]
5. Chelators for radioimmunotherapy: I. NMR and ab initio calculation studies on 1,4,7,10-tetra(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO4Pr) and 1,4,7-tris(carboxymethyl)-10-(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO3A1Pr).
Keire DA; Jang YH; Li L; Dasgupta S; Goddard WA; Shively JE
Inorg Chem; 2001 Aug; 40(17):4310-8. PubMed ID: 11487337
[TBL] [Abstract][Full Text] [Related]
6. Labeling of oligonucleotides with DTPA and DOTA on solid phase.
Hovinen J
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1459-62. PubMed ID: 18066806
[TBL] [Abstract][Full Text] [Related]
7. Easy and efficient (111)indium labeling of long-term stored DTPA conjugated protein.
Nalla A; Buch I; Hesse B
Curr Radiopharm; 2011 Jan; 4(1):1-4. PubMed ID: 22191609
[TBL] [Abstract][Full Text] [Related]
8. Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers.
Shi J; Kim YS; Chakraborty S; Zhou Y; Wang F; Liu S
Amino Acids; 2011 Nov; 41(5):1059-70. PubMed ID: 20052508
[TBL] [Abstract][Full Text] [Related]
9. A cyclen-based tetraphosphinate chelator for the preparation of radiolabeled tetrameric bioconjugates.
Šimeček J; Hermann P; Havlíčková J; Herdtweck E; Kapp TG; Engelbogen N; Kessler H; Wester HJ; Notni J
Chemistry; 2013 Jun; 19(24):7748-57. PubMed ID: 23613345
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.
Boswell CA; Sun X; Niu W; Weisman GR; Wong EH; Rheingold AL; Anderson CJ
J Med Chem; 2004 Mar; 47(6):1465-74. PubMed ID: 14998334
[TBL] [Abstract][Full Text] [Related]
11. Metal-isotope-tagged monoclonal antibodies for high-dimensional mass cytometry.
Han G; Spitzer MH; Bendall SC; Fantl WJ; Nolan GP
Nat Protoc; 2018 Oct; 13(10):2121-2148. PubMed ID: 30258176
[TBL] [Abstract][Full Text] [Related]
12. Thiol-reactive lanthanide chelates for phasing protein X-ray diffraction data.
Purdy MD; Ge P; Chen J; Selvin PR; Wiener MC
Acta Crystallogr D Biol Crystallogr; 2002 Jul; 58(Pt 7):1111-7. PubMed ID: 12077430
[TBL] [Abstract][Full Text] [Related]
13. A Sensitive Method for the Measurement of Copper at Trace Levels Using an HPLC-Based Assay.
Dearling JLJ; Packard AB
Curr Radiopharm; 2017; 10(1):59-64. PubMed ID: 28124595
[TBL] [Abstract][Full Text] [Related]
14. H4octapa: an acyclic chelator for 111In radiopharmaceuticals.
Price EW; Cawthray JF; Bailey GA; Ferreira CL; Boros E; Adam MJ; Orvig C
J Am Chem Soc; 2012 May; 134(20):8670-83. PubMed ID: 22540281
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.
Sabbah EN; Kadouche J; Ellison D; Finucane C; Decaudin D; Mather SJ
Nucl Med Biol; 2007 Apr; 34(3):293-304. PubMed ID: 17383579
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates.
Ait-Mohand S; Fournier P; Dumulon-Perreault V; Kiefer GE; Jurek P; Ferreira CL; Bénard F; Guérin B
Bioconjug Chem; 2011 Aug; 22(8):1729-35. PubMed ID: 21761921
[TBL] [Abstract][Full Text] [Related]
17. Medicinal chemistry of somatostatin analogs leading to the DTPA and DOTA conjugates of the multi-receptor-ligand SOM230.
Lewis I; Albert R; Kneuer R; Pless J; Simeon C; Kerrad S; Hoyer D; Bruns C
J Endocrinol Invest; 2005; 28(11 Suppl International):15-20. PubMed ID: 16625840
[TBL] [Abstract][Full Text] [Related]
18. Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugates.
McMurry TJ; Pippin CG; Wu C; Deal KA; Brechbiel MW; Mirzadeh S; Gansow OA
J Med Chem; 1998 Aug; 41(18):3546-9. PubMed ID: 9719608
[TBL] [Abstract][Full Text] [Related]
19. Comparison of yttrium and indium complexes of DOTA-BA and DOTA-MBA: models for (90)Y- and (111)In-labeled DOTA-biomolecule conjugates.
Liu S; Pietryka J; Ellars CE; Edwards DS
Bioconjug Chem; 2002; 13(4):902-13. PubMed ID: 12121149
[TBL] [Abstract][Full Text] [Related]
20. A DOTA-peptide conjugate by copper-free click chemistry.
Martin ME; Parameswarappa SG; O'Dorisio MS; Pigge FC; Schultz MK
Bioorg Med Chem Lett; 2010 Aug; 20(16):4805-7. PubMed ID: 20630750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
